| The Metals Opportunity Powering America's Comeback (ad) |
Washington's New Metals Push Looks to Spark a U.S. Comeback
America's next industrial revolution may not happen in Silicon Valley or on Wall St. - it's starting underground.
As the U.S. faces mounting threats to its energy independence and defense supply chain, Washington is racing to rebuild access to the metals that make modern life possible...uranium, lithium, titanium, and vanadium.
See how this rare critical-metals play could strengthen America's future > |
|
| Why you're worried about America (ad) |
Rich or poor, left or right, young or old, a dark cloud is hanging over the nation. Everyone senses something is coming. They just don't know what it is or when it will hit. This division isn't really about politics or left versus right. These cracks and unrest are symptoms of something far deeper. It's the real reason support for socialism is soaring, why nearly 70 percent believe the American Dream is dead, and why Americans from coast to coast are losing hope. It's all connected, and most people don't understand it.
Click here to reveal the truth behind the nationwide unease. |
|
Recent U.S. Insider Buying | Company | Insider Name | Buy/Sell | Shares | Total Transaction | Transaction Date | Current Price | SEC Filing | BDSX
Biodesix | Jack W Schuler Director | Buy | 80,000 shares @ $11.81 | $944,800.00 | 1/23/2026 | $10.32 |  | BDSX
Biodesix | Jack W Schuler Director | Buy | 20,000 shares @ $11.80 | $236,000.00 | 1/26/2026 | $10.32 | | BST
BlackRock Science and Technology Trust | Tony Kim Portfolio Manager | Buy | 16,000 shares @ $40.70 | $651,200.00 | 1/23/2026 | $41.19 | | HYMC
Hycroft Mining | Eric Sprott Major Shareholder | Buy | 100,000 shares @ $49.96 | $4,996,000.00 | 1/26/2026 | $50.28 | | INTC
Intel | David Zinsner EVP | Buy | 5,882 shares @ $42.50 | $249,985.00 | 1/26/2026 | $48.96 | | JYNT
Joint | Charles E Jobson Major Shareholder | Buy | 16,753 shares @ $10.00 | $167,530.00 | 1/23/2026 | $9.63 | | MIRM
Mirum Pharmaceuticals | Patrick J Heron Director | Buy | 131,425 shares @ $68.48 | $8,999,984.00 | 1/23/2026 | $100.66 | | PRU
Prudential Financial | Insurance Co Of Ame Prudential Major Shareholder | Buy | 1,406,739 shares @ $24.87 | $34,985,598.93 | 1/23/2026 | $107.37 | | STEX
Biosig Technologies | Frank Giustra Major Shareholder | Buy | 1,000,000 shares @ $3.00 | $3,000,000.00 | 1/23/2026 | $3.79 | | THM
International Tower Hill Mines | Paulson & Co. Inc. Major Shareholder | Buy | 18,018,018 shares @ $2.22 | $39,999,999.96 | 1/27/2026 | $2.98 | | VANI
Vivani Medical | Gregg Williams Director | Buy | 1,351,351 shares @ $1.48 | $1,999,999.48 | 1/27/2026 | $1.49 | |
| I'm a Futurist: Here are 3 stocks better than Nvidia (ad) |
Nvidia's own customers could soon become fierce competitors, dethroning the AI Chip King. But there's a critical component that AI data centers need just as badly as chips. The demand is so massive that a single data center uses enough of it to stretch around the earth eight times. While the media hypes up AI chips, the smart money has found the next big thing. Discover Futurist Eric Fry's "Nvidia-killer" stock ideas.
Click here for complete analysis. |
|
Recent U.S. Insider Selling | Company | Insider Name | Buy/Sell | Shares | Total Transaction | Transaction Date | Current Price | SEC Filing | ACN
Accenture | Catherine Kiernan Hogan COO | Sell | 660 shares @ $280.93 | $185,413.80 | 1/26/2026 | $268.92 | | ACN
Accenture | Melissa A Burgum CAO | Sell | 3,588 shares @ $281.01 | $1,008,263.88 | 1/26/2026 | $268.92 | | ACN
Accenture | John F Walsh CEO | Sell | 3,986 shares @ $276.38 | $1,101,650.68 | 1/27/2026 | $268.92 | | ADBE
Adobe | Daniel Durn CFO | Sell | 1,646 shares @ $294.85 | $485,323.10 | 1/27/2026 | $299.26 | | AZO
AutoZone | Richard Craig Smith VP | Sell | 5,910 shares @ $3,700.00 | $21,867,000.00 | 1/23/2026 | $3,787.86 | | BTGO
BTGO | Jody Mettler COO | Sell | 25,000 shares @ $16.74 | $418,500.00 | 1/23/2026 | $13.39 | | BTGO
BTGO | Edward Reginelli CFO | Sell | 45,000 shares @ $16.74 | $753,300.00 | 1/23/2026 | $13.39 | | BTGO
BTGO | Chen Fang CRO | Sell | 250,000 shares @ $16.74 | $4,185,000.00 | 1/23/2026 | $13.39 | | BTGO
BTGO | Jeff Peter Horowitz Insider | Sell | 116,007 shares @ $16.74 | $1,941,957.18 | 1/23/2026 | $13.39 | | FAST
Fastenal | Scott Satterlee Director | Sell | 15,964 shares @ $44.19 | $705,449.16 | 1/23/2026 | $43.72 | | FLOC
Flowco | Chad Roberts EVP | Sell | 40,884 shares @ $21.47 | $877,779.48 | 1/23/2026 | $19.88 | | GRND
Grindr | James Fu Bin Lu Major Shareholder | Sell | 239,000 shares @ $11.97 | $2,860,830.00 | 1/26/2026 | $11.71 | | GRND
Grindr | James Fu Bin Lu Major Shareholder | Sell | 200,000 shares @ $11.74 | $2,348,000.00 | 1/27/2026 | $11.71 | | GS
The Goldman Sachs Group | Carey Halio Treasurer | Sell | 1,757 shares @ $920.62 | $1,617,529.34 | 1/23/2026 | $930.79 | | GS
The Goldman Sachs Group | Kathryn H Ruemmler Insider | Sell | 9,589 shares @ $927.51 | $8,893,893.39 | 1/23/2026 | $930.79 | | GS
The Goldman Sachs Group | Sheara J Fredman CAO | Sell | 4,863 shares @ $923.75 | $4,492,196.25 | 1/23/2026 | $930.79 | | GSBC
Great Southern Bancorp | Joseph W Turner CEO | Sell | 6,000 shares @ $60.74 | $364,440.00 | 1/26/2026 | $59.61 | | HGTY
Hagerty | Kenneth Ahn Insider | Sell | 50,000 shares @ $12.41 | $620,500.00 | 1/26/2026 | $12.48 | | IAE
Voya Asia Pacific High Dividend Equity Income Fund | Saba Capital Management, L.P. Major Shareholder | Sell | 31,461 shares @ $8.14 | $256,092.54 | 1/26/2026 | $8.26 | | IRMD
iRadimed | Roger E Susi CEO | Sell | 5,000 shares @ $100.65 | $503,250.00 | 1/26/2026 | $97.32 | | LTH
Life Time Group | Ritadhwaja Jebens Singh EVP | Sell | 12,088 shares @ $29.75 | $359,618.00 | 1/23/2026 | $28.92 | | MIRM
Mirum Pharmaceuticals | Peter Radovich COO | Sell | 3,143 shares @ $96.19 | $302,325.17 | 1/26/2026 | $100.66 | | MIRM
Mirum Pharmaceuticals | Christopher Peetz CEO | Sell | 6,831 shares @ $96.19 | $657,073.89 | 1/26/2026 | $100.66 | | NAMS
NewAmsterdam Pharma | Louise Frederika Kooij CAO | Sell | 38,172 shares @ $33.75 | $1,288,305.00 | 1/23/2026 | $31.98 | | NAMS
NewAmsterdam Pharma | Louise Frederika Kooij CAO | Sell | 34,400 shares @ $32.78 | $1,127,632.00 | 1/26/2026 | $31.98 | | NTRS
Northern Trust | Peter Cherecwich COO | Sell | 25,000 shares @ $149.62 | $3,740,500.00 | 1/26/2026 | $149.58 | | PTGX
Protagonist Therapeutics | Dinesh V Ph D Patel CEO | Sell | 24,890 shares @ $84.03 | $2,091,506.70 | 1/26/2026 | $83.05 | | PTGX
Protagonist Therapeutics | Dinesh V Ph D Patel CEO | Sell | 19,315 shares @ $84.59 | $1,633,855.85 | 1/23/2026 | $83.05 | | PTGX
Protagonist Therapeutics | Dinesh V Ph D Patel CEO | Sell | 4,068 shares @ $83.19 | $338,416.92 | 1/27/2026 | $83.05 | | PTGX
Protagonist Therapeutics | Asif Ali CFO | Sell | 46,203 shares @ $83.13 | $3,840,855.39 | 1/27/2026 | $83.05 | | PTGX
Protagonist Therapeutics | Arturo Md Molina Insider | Sell | 5,000 shares @ $82.00 | $410,000.00 | 1/27/2026 | $83.05 | | PTGX
Protagonist Therapeutics | Arturo Md Molina Insider | Sell | 13,151 shares @ $82.42 | $1,083,905.42 | 1/23/2026 | $83.05 | | SLB
SLB | Stephane Biguet CFO | Sell | 61,017 shares @ $49.70 | $3,032,544.90 | 1/26/2026 | $48.85 | | SLB
SLB | Dianne B Ralston Insider | Sell | 18,617 shares @ $49.50 | $921,541.50 | 1/26/2026 | $48.85 | | SLB
SLB | Abdellah Merad EVP | Sell | 60,000 shares @ $49.70 | $2,982,000.00 | 1/26/2026 | $48.85 | | SLB
SLB | Howard Guild CAO | Sell | 13,268 shares @ $49.70 | $659,419.60 | 1/26/2026 | $48.85 | | SLB
SLB | La Chevardiere Patrick De Director | Sell | 4,000 shares @ $50.29 | $201,160.00 | 1/26/2026 | $48.85 | | SYM
Symbotic | James Kuffner CTO | Sell | 77,321 shares @ $59.76 | $4,620,702.96 | 1/26/2026 | $54.78 | | SYM
Symbotic | Maria G Freve Insider | Sell | 6,667 shares @ $59.99 | $399,953.33 | 1/26/2026 | $54.78 | | TEAM
Atlassian | Michael Cannon-Brookes CEO | Sell | 7,665 shares @ $136.93 | $1,049,568.45 | 1/26/2026 | $134.48 | | TEAM
Atlassian | Scott Farquhar Director | Sell | 7,665 shares @ $136.93 | $1,049,568.45 | 1/26/2026 | $134.48 | | TFC
Truist Financial | Michael Baron Maguire CFO | Sell | 13,000 shares @ $50.13 | $651,690.00 | 1/26/2026 | $50.16 | | TSHA
Taysha Gene Therapies | Sukumar Nagendran Insider | Sell | 89,132 shares @ $4.75 | $423,377.00 | 1/23/2026 | $4.55 | | TSHA
Taysha Gene Therapies | Sean P Nolan CEO | Sell | 136,789 shares @ $4.75 | $649,747.75 | 1/23/2026 | $4.55 | | TSHA
Taysha Gene Therapies | Sean P Nolan CEO | Sell | 41,312 shares @ $4.61 | $190,448.32 | 1/26/2026 | $4.55 | | TSHA
Taysha Gene Therapies | Kamran Alam CFO | Sell | 78,968 shares @ $4.75 | $375,098.00 | 1/23/2026 | $4.55 | | TVTX
Travere Therapeutics | Eric M Dube CEO | Sell | 51,865 shares @ $30.10 | $1,561,136.50 | 1/27/2026 | $30.19 | | TVTX
Travere Therapeutics | Eric M Dube CEO | Sell | 8,135 shares @ $30.01 | $244,131.35 | 1/23/2026 | $30.19 | | W
Wayfair | Steven Conine Insider | Sell | 150,000 shares @ $108.87 | $16,330,500.00 | 1/23/2026 | $108.09 | | W
Wayfair | Niraj Shah CEO | Sell | 150,000 shares @ $108.87 | $16,330,500.00 | 1/23/2026 | $108.09 | |
| How I'm investing in AI (ad) |
Every investor is chasing the same names: Nvidia, Palantir, Alphabet, and the rest of the Mag7. But those stocks are trading at steep valuations while most consumers and businesses struggle beneath the surface. That doesn't mean AI is going away. Adoption will accelerate, and the models will get better, faster, and smarter. While other investors speculate on which startup will survive the inevitable reset, there's a different approach. In this rapidly evolving landscape, it's nearly impossible to pick winners and losers. Instead, focus on what's all but guaranteed.
See how to position for AI without chasing overvalued stocks. |
|
Top Insider-Buying Stocks (Last 30 Days) | Company | Shares Purchased | Total Cost of Shares Purchased | Number of Insider Purchases | Number of Insiders Buying | Current Share Price | MarketBeat Consensus Rating | MarketBeat Consensus Price Target | Read More | | SPG Simon Property Group | 2,192 | $407,712.00 | 10 | 10 | $184.04 | Hold | $194.64 | | | YORW York Water | 493 | $15,012.00 | 7 | 7 | $32.82 | Hold | $0.00 | | | CABA Cabaletta Bio | 127,668 | $286,211.00 | 7 | 7 | $2.85 | Moderate Buy | $16.25 | | | AKTS Aktis Oncology | 6,117,776 | $110,119,968.00 | 5 | 5 | $20.46 | N/A | $0.00 | | | IMRX Immuneering | 51,819 | $234,472.00 | 5 | 5 | $5.06 | Moderate Buy | $16.50 | | | INDV Indivior | 4,871 | $172,385.00 | 5 | 5 | $34.77 | Moderate Buy | $39.33 | | | ISBA Isabella Bank | 1,397 | $69,266.00 | 6 | 5 | $50.25 | Hold | $38.50 | | | RCG RENN Fund | 12,518 | $33,285.00 | 26 | 5 | $2.75 | N/A | $0.00 | | | NEWT NewtekOne | 8,656 | $120,405.00 | 4 | 4 | $13.60 | Hold | $14.50 | | | ALMS Alumis | 1,823,527 | $30,999,959.00 | 4 | 4 | $26.47 | Moderate Buy | $37.50 | |
Top Insider-Selling Stocks (Last 30 Days) | Company | Shares Sold | Total Cost of Shares Sold | Number of Insider Sales | Number of Insiders Selling | Current Share Price | MarketBeat Consensus Rating | MarketBeat Consensus Price Target | Read More | | IONS Ionis Pharmaceuticals | 188,795 | $14,753,264.00 | 14 | 10 | $81.95 | Moderate Buy | $86.45 | | | KTOS Kratos Defense & Security Solutions | 266,390 | $24,959,168.00 | 12 | 9 | $112.54 | Moderate Buy | $95.28 | | | PTCT PTC Therapeutics | 69,210 | $5,316,898.00 | 29 | 9 | $76.24 | Moderate Buy | $80.67 | | | QSR Restaurant Brands International | 13,701 | $924,066.00 | 9 | 9 | $67.62 | Hold | $76.57 | | | RNA Avidity Biosciences | 58,407 | $4,226,448.00 | 13 | 8 | $72.57 | Hold | $69.57 | | | SRRK Scholar Rock | 168,219 | $7,326,772.00 | 10 | 8 | $43.67 | Buy | $51.14 | | | LQDA Liquidia | 210,266 | $7,870,256.00 | 8 | 8 | $41.89 | Moderate Buy | $39.67 | | | EQIX Equinix | 10,886 | $8,748,298.00 | 8 | 8 | $824.70 | Moderate Buy | $959.64 | | | APLS Apellis Pharmaceuticals | 115,169 | $2,477,931.00 | 23 | 8 | $23.28 | Hold | $33.00 | | | ACN Accenture | 16,017 | $4,505,916.00 | 9 | 7 | $268.92 | Moderate Buy | $298.38 | |
| Thank you for subscribing to InsiderTrades.com's Insider Trades Daily Newsletter! We are committed to providing the most complete and most accurate coverage of corporate insider buying and selling activity disclosed to the Securities and Exchange Commission. InsiderTrades.com is a subsidiary of MarketBeat Media, LLC and MarketBeat.com. If you need assistance with your account, please contact our U.S. based support team at contact@marketbeat.com. Unsubscribe Copyright 2006-2026 MarketBeat Media, LLC. 345 North Reid Place, Sixth Floor, Sioux Falls, SD 57103. United States. . From Our Partners: Did the government just make a $500 trillion mistake? (From Behind the Markets) | |
Post a Comment
Post a Comment